[ad_1] Federal health officials are investigating whether there is a link between BioNTech BNTX, -1.28% and Pfizer’s PFE, -3.70% bivalent COVID-19 booster and stroke in seniors. The Centers and Disease…
[ad_1] Pfizer PFE, +0.28% is the latest pandemic stock to face questions about its long-term strategy as revenue from its COVID-19 vaccine and antiviral business starts to dry up. Bank…
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for marketing authorization in the European Union for advanced liver and lung cancer. The Anglo-Swedish pharma…
[ad_1] If you’re suffering from hair loss, then zinc, pumpkin-seed oil and an active ingredient found in chili peppers may actually help, according to a new report. A new research…
[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive decline after a year and a half. Eisai’s 4523, +3.83% stock was up 1.7%% in…
[ad_1] As Americans brace for what could be a brutal flu season, the U.S. Centers for Disease Control and Prevention has issued a report showing that Black, Hispanic and American…
[ad_1] GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker…